Action 6499 MEDEON BIODESIGN, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Medeon Biodesign, Inc.

Actions

6499

TW0006499007

Cours en clôture Taipei Exchange
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
42,45 TWD -1,16 % Graphique intraday de Medeon Biodesign, Inc. +0,59 % -9,00 %
08/03 Medeon Biodesign, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Medeon Biodesign, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc.
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Medeon Biodesign, Inc.(TPEX:6499) added to S&P Global BMI Index
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 6499
  4. Actualités Medeon Biodesign, Inc.
  5. Autres langues